by Fetal Health Foundation | Apr 29, 2021 | Blogs, front-page, News, Twin-to-Twin Transfusion Syndrome
Upon meeting with Colorado Fetal Care Center maternal fetal medicine specialist and fetal surgeon Nick Behrendt, MD, the Oligmuellers learned their case of TTTS was severe. The best solution for TTTS is typically fetoscopic laser ablation. It’s a minimally invasive surgery in which the surgeon inserts a tiny scope into the uterus, through the amniotic sac.
by Fetal Health Foundation | Apr 20, 2021 | Conjoined Twins, front-page, News, Story
The team at UC Davis decided to separate these conjoined twins at 9 months of age. They took special precautions such as house calls during COVID to give the girls the best chance at an amazing life.
by Fetal Health Foundation | Jan 29, 2021 | Blogs, Fetal Hydrops, front-page, Grant Winner, News
We’re happy to share exciting news from recipients of our two-time research grant winner! In 2018 and 2019, the Fetal Health Foundation teamed up with the Brianna Marie Foundation to support Dr. Teresa Sparks and her team at the University of California, San...
by Fetal Health Foundation | Jan 8, 2021 | front-page, News
Dr. Timothy Crombleholme, Director Fetal Care Center of Dallas, and Lonnie Somers, Chair and Founder of the Fetal Health Foundation announce the joining of the Fetal Therapy Think Tank and the Fetal Health Foundation as one organization with the mission of improving...
by Fetal Health Foundation | Dec 9, 2020 | front-page, Myelomeningocele/Spina Bifida, News, Spina Bifida
With the CIRM funding, the UC Davis team will be able to launch their one-of-a-kind treatment in the coming months. It will be delivered while the baby is still in the mother’s womb (in utero). The complex procedure, with its unique use of a stem cell “patch,” could improve outcomes for children who are born with the severe form of spina bifida known as myelomeningocele.
by Fetal Health Foundation | Dec 3, 2020 | Blogs, COVID-19, News
“In general, SMFM strongly recommends that pregnant women have access to COVID-19 vaccines in all phases of future vaccine campaigns, and that she and her healthcare professional engage in shared decision-making regarding her receipt of the vaccine. Counseling should balance available data on vaccine safety, risks to pregnant women from SARS-CoV-2 infection, and a woman’s individual risk for infection and severe disease. As data emerge, counseling will likely shift, as some vaccines may be more suitable for pregnant women.